NUCLEOTID-VAKZINE

European patent · EP1957528 · In force

Register entry

Publication number
EP1957528
Application number
EP06818135
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 30, 2006
Published
Aug 20, 2008
Granted
Nov 7, 2012
Protection ends at the latest
Nov 29, 2026
Next annual fee due
Nov 30, 2026
IPC classes
C07K 14/705 (2006.01)
Priority
DK 200501697 30.11.2005
DK 200501857 30.12.2005
US 755712 P 30.12.2005
DK 200600431 27.03.2006
PCT application
PCT/DK2006/000675 30.11.2006
PCT publication
WO2007/062656 07.06.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Dec 20, 2012

    Agent entered

    Representative
    Hans Ulrich Seifert, Seifert & Partner, Pestalozzistrasse 2 /Postfach 1416, 8201 Schaffhausen

    Published in Swissreg on 20.12.2012

  6. Nov 7, 2012

    Granted

    Published in Swissreg on 07.11.2012

Parties

Holder

University of Copenhagen

Postbox 2177, Norregade 10, 1017 Copenhagen K, DK

Agent

Hans Ulrich Seifert Seifert & Partner

Pestalozzistrasse 2 /Postfach 1416, 8201 Schaffhausen

Inventor

HOLST, Peter Johannes

DK-2700 Bronshoj, DK

THOMSEN, Allan Randrup

DK-2100 Copenhagen Ø, DK

CHRISTENSEN, Jan Pravsgaard

DK-2650 Hvidovre, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.